Article
CYP17 genotype and breast cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Oct 1998
Weston A, Pan C F, Bleiweiss I J, Ksieski H B, Roy N, Maloney N, Wolff M S
Abstract excerpt
The MspAI polymorphism in the 5' untranslated region of CYP17 has been evaluated as a breast cancer risk factor in a hospital-based case-control study in New York City. The study population consisted of 363 women [123 breast cancer patients and 240 patient controls (123 benign breast disease with...
Topics
- Black People
- Breast Neoplasms
- Case-Control Studies
- Female
- Gene Frequency
- Genetic Predisposition to Disease
- Genotype
- Hispanic or Latino
- Humans
- Menarche
- New York City
- Odds Ratio
- Polymorphism, Genetic
- Postmenopause
- Premenopause
- Risk Factors
- Steroid 17-alpha-Hydroxylase
- White People